​

AngioDynamics (ANGO) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

ANGO Stock Forecast

AngioDynamics (ANGO) stock forecast, based on 10 Wall Street analysts, predicts a 12-month average price target of $15.00, with a high of $22.00 and a low of $12.00. This represents a 58.56% increase from the last price of $9.46.

$5 $9 $13 $17 $21 $25 High: $22 Avg: $15 Low: $12 Last Closed Price: $9.46

ANGO Stock Rating

AngioDynamics stock's rating consensus is Buy, based on 10 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (50.00%), 5 Hold (50.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 10 0 5 5 Strong Sell Sell Hold Buy Strong Buy

ANGO Price Target Upside V Benchmarks

TypeNameUpside
StockAngioDynamics58.56%
SectorHealthcare Stocks 33.91%
IndustryMedical Instruments & Supplies Stocks33.03%

Price Target Trends

1M3M12M
# Anlaysts--2
Avg Price Target--$13.00
Last Closing Price$9.46$9.46$9.46
Upside/Downside--37.42%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 2512---3
Mar, 2512---3
Feb, 2512---3
Jan, 2512---3
Dec, 2412---3
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 04, 2024William PlovanicCanaccord Genuity$12.00$6.1096.72%26.85%
Sep 20, 2024Yi ChenH.C. Wainwright$14.00$7.7081.82%47.99%
Apr 05, 2024Steven LichtmanOppenheimer$12.00$6.4087.50%26.85%
Jan 06, 2023Raymond James$22.00$15.4842.12%132.56%
Jul 13, 2022Raymond James$27.00$20.0234.87%185.41%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Apr 07, 2025H.C. WainwrightBuyBuyhold
Jan 10, 2025OppenheimerOutperformOutperformhold
Jan 10, 2025H.C. WainwrightBuyBuyhold
Oct 04, 2024OppenheimerOutperformOutperformhold
Oct 04, 2024William BlairBuyBuyhold
Oct 04, 2024Canaccord GenuityBuyBuyhold
Oct 03, 2024Raymond JamesOutperformOutperformhold
Sep 20, 2024H.C. WainwrightBuyBuyhold
Apr 05, 2024OppenheimerOutperformupgrade
Jan 09, 2024Raymond JamesOutperformOutperformhold

Financial Forecast

EPS Forecast

$-5 $-4 $-3 $-2 $-1 $0 $1 May 20 May 21 May 22 May 23 May 24 May 25 May 26 May 27 May 28 May 29
May 20May 21May 22May 23May 24May 25May 26May 27May 28May 29
Reported$-4.37$-0.82$-0.68$-1.33$-4.59-----
Avg Forecast$0.09$0.05$-0.01$-0.06$-0.52$-0.37$-0.21$0.09$0.44$0.55
High Forecast$0.09$0.05-$-0.06$-0.51$-0.35$-0.16$0.09$0.45$0.56
Low Forecast$0.09$0.05$-0.01$-0.06$-0.52$-0.38$-0.25$0.09$0.44$0.54
Surprise %-4955.56%-1740.00%6700.00%2116.67%782.69%-----

Revenue Forecast

$250M $280M $310M $340M $370M $400M May 20 May 21 May 22 May 23 May 24 May 25 May 26 May 27 May 28 May 29
May 20May 21May 22May 23May 24May 25May 26May 27May 28May 29
Reported$264.16M$291.01M$316.22M$338.75M$303.91M-----
Avg Forecast$268.37M$286.73M$312.13M$338.40M$270.63M$284.89M$303.80M$326.80M$357.60M$390.30M
High Forecast$270.17M$288.65M$314.21M$341.76M$286.00M$285.38M$308.91M$330.04M$361.15M$394.17M
Low Forecast$266.10M$284.30M$309.48M$335.99M$255.27M$284.52M$300.51M$324.48M$355.06M$387.53M
Surprise %-1.57%1.49%1.31%0.10%12.30%-----

Net Income Forecast

$-250M $-190M $-130M $-70M $-10M $50M May 20 May 21 May 22 May 23 May 24 May 25 May 26 May 27 May 28 May 29
May 20May 21May 22May 23May 24May 25May 26May 27May 28May 29
Reported$-165.79M$-31.55M$-26.55M$-52.44M$-184.35M-----
Avg Forecast$-17.37M$-187.44M$-200.90K$-2.25M$-14.12M$-14.67M$-8.24M$3.62M$17.68M$22.10M
High Forecast$-13.53M$-149.95M$-198.69K$-2.23M$-11.29M$-14.06M$-6.59M$3.66M$17.91M$22.38M
Low Forecast$-21.21M$-224.93M$-202.65K$-2.28M$-16.94M$-15.27M$-9.89M$3.58M$17.52M$21.90M
Surprise %854.42%-83.17%13113.77%2229.58%1205.96%-----

ANGO Forecast FAQ

Is AngioDynamics stock a buy?

AngioDynamics stock has a consensus rating of Buy, based on 10 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 5 Buy, 5 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that AngioDynamics is a favorable investment for most analysts.

What is AngioDynamics's price target?

AngioDynamics's price target, set by 10 Wall Street analysts, averages $15 over the next 12 months. The price target range spans from $12 at the low end to $22 at the high end, suggesting a potential 58.56% change from the previous closing price of $9.46.

How does AngioDynamics stock forecast compare to its benchmarks?

AngioDynamics's stock forecast shows a 58.56% upside, outperforming the average forecast for the healthcare stocks sector (33.91%) and outperforming the medical instruments & supplies stocks industry (33.03%).

What is the breakdown of analyst ratings for AngioDynamics over the past three months?

  • April 2025: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is AngioDynamics’s EPS forecast?

AngioDynamics's average annual EPS forecast for its fiscal year ending in May 2025 is $-0.37, marking a -91.94% decrease from the reported $-4.59 in 2024. Estimates for the following years are $-0.21 in 2026, $0.09 in 2027, $0.44 in 2028, and $0.55 in 2029.

What is AngioDynamics’s revenue forecast?

AngioDynamics's average annual revenue forecast for its fiscal year ending in May 2025 is $284.89M, reflecting a -6.26% decrease from the reported $303.91M in 2024. The forecast for 2026 is $303.8M, followed by $326.8M for 2027, $357.6M for 2028, and $390.3M for 2029.

What is AngioDynamics’s net income forecast?

AngioDynamics's net income forecast for the fiscal year ending in May 2025 stands at $-14.666M, representing a -92.04% decrease from the reported $-184M in 2024. Projections indicate $-8.242M in 2026, $3.62M in 2027, $17.68M in 2028, and $22.1M in 2029.